447 genotypes with 491 annotations displayed
of selected term and subterms
|
Searched Term: decreased tumor incidence
|
2610035D17Rikem1Zhgn/2610035D17Rikem1Zhgn Krasem1Gpt/Kras+ Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6JGpt * CBA)
|
decreased gland tumor incidence
|
J:339253
|
2610035D17Rikem2Zhgn/2610035D17Rikem2Zhgn Krasem1Gpt/Kras+ Tg(Pdx1-cre)89.1Dam/0 Trp53em3Gpt/Trp53+
(involves: C57BL/6JGpt * CBA)
|
decreased gland tumor incidence
|
J:339253
|
Ay/Aw
(129S1.C3-Ay/Aw Chr 19MOLF/Ei)
|
decreased incidence of induced tumors
|
J:146879
|
Adam15tm1Bbl/Adam15tm1Bbl
(involves: 129X1/SvJ * C57BL/6J)
|
decreased tumor incidence
|
J:217858
|
Adam15tm2.1Bbl/Adam15tm2.1Bbl
(involves: 129 * 129P2/OlaHsd * C57BL/6J * SJL)
|
decreased tumor incidence
|
J:217858
|
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd)
|
decreased incidence of tumors by chemical induction
|
J:103404
|
Aggf1Gt(PT036)Byg/Aggf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased tumor incidence
|
J:239252
|
Aggf1tm1Qkw/Aggf1+
(involves: 129 * C57BL/6)
|
decreased tumor incidence
|
J:239252
|
Agtr2tm1Tin/Y
(SWR.129P2-Agtr2tm1Tin)
|
decreased incidence of tumors by chemical induction
|
J:101726
|
Ahrrtm1Yfk/Ahrrtm1Yfk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:130214
|
ApcMin/Apc+
(involves: C57BL/6J)
|
decreased intestinal adenoma incidence
|
J:268691
|
ApcMin/Apc+
((AKR/J x C57BL/6J-ApcMin)F1)
|
decreased intestinal adenoma incidence
|
J:1879
|
ApcMin/Apc+
((MA/MyJ x C57BL/6J-ApcMin)F1)
|
decreased intestinal adenoma incidence
|
J:1879
|
ApcMin/Apc+ Arhgef4tm1Taki/Arhgef4+
(B6J.Cg-Arhgef4tm1Taki ApcMin)
|
decreased intestinal adenoma incidence
|
J:157023
|
ApcMin/Apc+ Arhgef4tm1Taki/Arhgef4tm1Taki
(B6J.Cg-Arhgef4tm1Taki ApcMin)
|
decreased intestinal adenoma incidence
|
J:157023
|
ApcMin/Apc+ Arhgef4tm1Taki/Arhgef4tm1Taki Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Arhgef4tm1Taki Spata13tm1Taki ApcMin)
|
decreased intestinal adenoma incidence
|
J:157023
|
ApcMin/Apc+ Atp5f1aMom2/Atp5f1a+
(involves: C57BL/6J * DBA/2J)
|
decreased tumor incidence
|
J:73854
|
ApcMin/Apc+ Atp5f1aMom2/Atp5f1aMom2
(involves: C57BL/6J * DBA/2J)
|
decreased tumor incidence
|
J:73854
|
ApcMin/Apc+ Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased intestinal adenoma incidence
|
J:135025
|
ApcMin/Apc+ Cd44tm1Mak/Cd44tm1Mak
(involves: C57BL/6J)
|
decreased intestinal adenoma incidence
|
J:204874
|
ApcMin/Apc+ Cd44tm2Stpa/Cd44tm2Stpa
(involves: C57BL/6J)
|
decreased intestinal adenoma incidence
|
J:204874
|
ApcMin/Apc+ Col1a1tm1(CAG-Sirt1)Dsin/Col1a1+ Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL)
|
decreased tumor incidence
|
J:134301
|
ApcMin/Apc+ Del(15Rr357-Rr303293)2Jta/Del(15Rr357-Rr303293)2Jta
(involves: C57BL/6)
|
decreased colon tumor incidence
|
J:257088
|
ApcMin/Apc+ Dnmt3btm1Jae/Dnmt3btm1Jae Tg(Fabp1-cre)1Jig/0
(involves: 129 * C57BL/6 * C57BL/6J * FVB/N)
|
decreased tumor incidence
|
J:107386
|
ApcMin/Apc+ EgfrWa5/Egfr+
(involves: BALB/cAnN * C3H/HeN * C57BL/6J)
|
decreased tumor incidence
|
J:92308
|
ApcMin/Apc+ Elp3tm1.1Tac/Elp3tm1.1Tac Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * C57BL/6NTac * SJL)
|
decreased intestinal adenoma incidence
|
J:227334
|
ApcMin/Apc+ Erbb3tm1.1Dwt/Erbb3tm2.1Dwt Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
decreased tumor incidence
|
J:152703
|
ApcMin/Apc+ Gt(ROSA)26Sor/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sor ApcMin)
|
decreased alimentary system tumor incidence
|
J:66060
|
decreased incidence of tumors by chemical induction
|
J:66060
|
decreased mammary gland tumor incidence
|
J:66060
|
ApcMin/Apc+ Hdac2Gt(W035F03)Joe/Hdac2Gt(W035F03)Joe
(involves: 129S2/SvPas * C57BL/6J)
|
decreased tumor incidence
|
J:152134
|
ApcMin/Apc+ Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * C57BL/6 * C57BL/6J)
|
decreased alimentary system tumor incidence
|
J:189217
|
ApcMin/Apc+ Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * BALB/cJ * C57BL/6J)
|
decreased tumor incidence
|
J:262876
|
ApcMin/Apc+ Mapkapk2tm1.2Gkl/Mapkapk2tm1.2Gkl
(involves: BALB/cJ * C57BL/6J)
|
decreased tumor incidence
|
J:262876
|
ApcMin/Apc+ Mbd2tm1Bh/Mbd2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
decreased tumor incidence
|
J:83087
|
ApcMin/Apc+ Mbd2tm1Bh/Mbd2tm1Bh
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
decreased tumor incidence
|
J:83087
|
ApcMin/Apc+ Mmom1C57BL/6J/Mmom1FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom1C57BL/6J/Mmom1FVB/NTac Mmom3C57BL/6J/Mmom3FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom2129X1/SvJ/Mmom2C57BL/6J
(involves: 129X1/SvJ * C57BL/6J)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom2C57BL/6J/Mmom2FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom2C57BL/6J/Mmom2FVB/NTac Mmom3C57BL/6J/Mmom3FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom2C57BL/6J/Mmom2FVB/NTac Mmom4C57BL/6J/Mmom4FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mmom4C57BL/6J/Mmom4FVB/NTac
(involves: C57BL/6J * FVB/NTac)
|
decreased mammary gland tumor incidence
|
J:128481
|
ApcMin/Apc+ Mom5129P2/OlaHsd/?
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of induced tumors
|
J:152194
|
ApcMin/Apc+ Nos2tm1Lau/Nos2+
(B6.Cg-Nos2tm1Lau ApcMin)
|
decreased tumor incidence
|
J:73152
|
ApcMin/Apc+ Nos2tm1Lau/Nos2tm1Lau
(B6.Cg-Nos2tm1Lau ApcMin)
|
decreased tumor incidence
|
J:73152
|
ApcMin/Apc+ Pla2g2aMom1-r/Pla2g2a+
(either: (AKR/J x C57BL/6J-ApcMin)F1 or (MA/MyJ x C57BL/6J-ApcMin)F1 or (CAST/EiJ x C57BL/6J-ApcMin)F1)
|
decreased alimentary system tumor incidence
|
J:15703
|
decreased intestinal adenoma incidence
|
J:15703
|
ApcMin/Apc+ Ptgs1tm1Unc/Ptgs1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased tumor incidence
|
J:64401
|
ApcMin/Apc+ Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased tumor incidence
|
J:64401
|
ApcMin/Apc+ Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased tumor incidence
|
J:64401
|
ApcMin/Apc+ Ptprhtm1.1Mato/Ptprhtm1.1Mato
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
decreased incidence of induced tumors
|
J:146871
|
ApcMin/Apc+ Spata13tm1Taki/Spata13+
(B6J.Cg-Spata13tm1Taki ApcMin)
|
decreased intestinal adenoma incidence
|
J:157023
|
ApcMin/Apc+ Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Spata13tm1Taki ApcMin)
|
decreased intestinal adenoma incidence
|
J:157023
|
ApcMin/Apc+ Tg(Vil1-PPARGC1A)#Amos/0
(involves: C57BL/6J * FVB/N)
|
decreased alimentary system tumor incidence
|
J:171361
|
ApcMin/Apc+ Tmem9tm1d(EUCOMM)Wtsi/Tmem9+
(involves: C57BL/6J * C57BL/6N)
|
decreased intestinal adenoma incidence
|
J:268691
|
ApcMin/Apc+ Tmem9tm1d(EUCOMM)Wtsi/Tmem9tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased intestinal adenoma incidence
|
J:268691
|
ApcMin/Apc+ Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J)
|
decreased alimentary system tumor incidence
|
J:241611
|
ApcMin/Apc+ Trp53tm2.1Tyj/Trp53tm2.1Tyj Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2)
|
decreased alimentary system tumor incidence
|
J:291671
|
ApcMin/Apc+ Zfp280cem1Xss/Zfp280cem1Xss
(C57BL/6J-ApcMin Zfp280cem1Xss)
|
decreased alimentary system tumor incidence
|
J:331404
|
ApcMin/ApcMin Sat1tm1Alh/Y
(involves: 129X1/SvJ * C57BL/6J)
|
decreased tumor incidence
|
J:99381
|
Apctm1Cip/Apc+ Mki67em1Dfis/Mki67em1Dfis
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:304800
|
Apctm1Mmt/Apc+ Mmp7tm1Lmm/Mmp7tm1Lmm Smad4tm1Mmt/Smad4+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
decreased tumor incidence
|
J:142797
|
Apctm1Rak/Apc+ Hmmrtm1Baa/Hmmrtm1Baa
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased tumor incidence
|
J:86065
|
Apctm1Tno/Apc+ Rac3tm1.1Bea/Rac3tm1.1Bea Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased alimentary system tumor incidence
|
J:306088
|
decreased intestinal adenoma incidence
|
J:306088
|
Apctm1Tno/Apctm1Tno Ctnnb1tm4.1Wbm/Ctnnb1+
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased tumor incidence
|
J:156864
|
Apctm2.1Cip/Apc+ Atg7tm1Tchi/Atg7tm1Tchi Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
decreased intestinal adenoma incidence
|
J:227287
|
Artm1.1Chc/Y
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:120844
|
Artm1.1Chc/Artm1.1Chc
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:120844
|
Artm3(AR)Dmr/Y Tg(TRAMP)8247Ng/0
(involves: 129S1/Sv * C57BL/6)
|
decreased tumor incidence
|
J:108849
|
Arl6ip5tm1.2Jwzh/Arl6ip5tm1.2Jwzh
(B6.129X1-Arl6ip5tm1.2Jwzh)
|
decreased incidence of tumors by chemical induction
|
J:187133
|
Armcx3tm1.1Eso/Y Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:345411
|
Atmtm1Awb/Atmtm1Awb Rad52tm1Aps/Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased lymphoma incidence
|
J:90941
|
Atmintm1.1Jhh/Atmintm1.1Jhh Cd79atm1(cre)Reth/Cd79a+ Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
decreased lymphoma incidence
|
J:230105
|
Bag1tm1Msd/Bag1+ Tg(SFTPC-RAF1-BxB)1Urr/0
(involves: C57BL/6)
|
decreased lung tumor incidence
|
J:95491
|
Bcl2tm1Mpin/Bcl2tm1Mpin Tg(SFTPC-RAF1-BxB)1Urr/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased tumor incidence
|
J:79696
|
Bmi1tm1.1Lees/Bmi1tm1.1Lees Apctm2Cip/Apc+ Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased alimentary system tumor incidence
|
J:204354
|
decreased colon tumor incidence
|
J:204354
|
decreased intestinal adenoma incidence
|
J:204354
|
Bmi1tm1Brn/Bmi1tm1Brn Apctm2Cip/Apc+ Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased alimentary system tumor incidence
|
J:204354
|
decreased colon tumor incidence
|
J:204354
|
decreased intestinal adenoma incidence
|
J:204354
|
Brca1tm1Brn/Brca1tm1.1Jjon Trp53tm1Brn/Trp53tm1Brn Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased mammary gland tumor incidence
|
J:178595
|
decreased skin tumor incidence
|
J:178595
|
Brca2tm1Mhun/Brca2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:89083
|
decreased tumor incidence
|
J:89083
|
Bts1C57BL/6JShi/?
(involves: C57BL/6JShi * NON/Shi)
|
decreased incidence of tumors by chemical induction
|
J:51984
|
Bts2C57BL/6JShi/?
(involves: C57BL/6JShi * NON/Shi)
|
decreased incidence of tumors by chemical induction
|
J:51984
|
Bub1tm1.1Jvd/Bub1+
(involves: 129/Sv * C57BL/6)
|
decreased tumor incidence
|
J:135093
|
Cacfd1tm1.1Geno/Cacfd1tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:184968
|
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:243363
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Catb/Catb
(C3.Cg-Catb/Anl)
|
decreased mammary gland tumor incidence
|
J:5971
|
Cav1tm1Mls/Cav1tm1Mls Tg(TRAMP)8247Ng/0
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased tumor incidence
|
J:133066
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
Ccnd1tm1Phin/Ccnd1tm1Phin Tg(MMTV-Erbb2)NK1Mul/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased mammary gland tumor incidence
|
J:105045
|
Ccnd1tm1Wbg/Ccnd1tm1Wbg Smarcb1tm1Gvk/Smarcb1+
(involves: 129/Sv * 129S2/SvPas * C57BL/6J * SJL/J)
|
decreased tumor incidence
|
J:101185
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2)
|
decreased lymphoma incidence
|
J:88120
|
Ccng1tm1Sst/Ccng1tm1Sst
(involves: 129S/SvEv * C57BL/6)
|
decreased hepatoma incidence
|
J:106007
|
decreased incidence of induced tumors
|
J:106007
|
Ccs1C57BL/6Ha/?
(involves: C57BL/6Ha * ICR/Ha)
|
decreased tumor incidence
|
J:19675
|
Cd28tm1Mak/Cd28tm1Mak Rc3h1san/Rc3h1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu)
|
decreased lymphoma incidence
|
J:189087
|
Cd34tm1Szk/Cd34tm1Szk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:121305
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased tumor incidence
|
J:147367
|
Cd79atm1(cre)Reth/Cd79a+ Dynll1tm1.1Jhh/Dynll1tm1.1Jhh Tg(IghMyc)22Bri/0
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth Tg(IghMyc)22Bri)
|
decreased lymphoma incidence
|
J:230105
|
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
|
decreased incidence of tumors by chemical induction
|
J:209990
|
Cd151tm1Mhe/Cd151tm1Mhe
(B6.129S-Cd151tm1Mhe)
|
decreased incidence of induced tumors
|
J:141595
|
Cd151tm2Nki/Cd151tm2Nki Itga3tm1Son/Itga3+ Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm)
|
decreased incidence of tumors by chemical induction
|
J:205736
|
Cd151tm2Nki/Cd151tm2Nki Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm)
|
decreased incidence of tumors by chemical induction
|
J:205736
|
Cdatm1d(EUCOMM)Wtsi/Cdatm1d(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:332259
|
Cdc25atm1Kiyo/Cdc25a+ Tg(MMTV-Erbb2)NK1Mul/?
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased incidence of induced tumors
|
J:123144
|
Cdc25atm1Kiyo/Cdc25a+ Tg(MMTV-vHaras)SH1Led/?
(involves: 129/Sv * C57BL/6 * C57BL/6J * CD-1)
|
decreased incidence of induced tumors
|
J:123144
|
Cdh13tm1Brns/Cdh13tm1Brns Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N)
|
decreased incidence of induced tumors
|
J:132759
|
Cdiptosem1Sunb/Cdiptosem1Sunb
(C57BL/6J-Cdiptosem1Sunb)
|
decreased incidence of tumors by chemical induction
|
J:321215
|
Cdk1tm2.1Kald/Cdk1tm2.1Kald Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129 * C57BL/6 * DBA * SJL)
|
decreased incidence of induced tumors
|
J:182141
|
Cdk2tm1Sgo/Cdk2tm1Sgo Krastm1Bbd/Kras+ Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased tumor incidence
|
J:161780
|
Cdk2tm2Sgo/Cdk2tm2Sgo Krastm1Bbd/Krastm2Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased tumor incidence
|
J:161780
|
Cdk4tm2.2Bbd/Cdk4tm2.1Bbd Krastm1Bbd/Krastm2Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased tumor incidence
|
J:161780
|
Cdk4tm2.2Bbd/Cdk4tm2.2Bbd Krastm1Bbd/Krastm1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased tumor incidence
|
J:161780
|
Cdkn1atm1Led/Cdkn1atm1Led
(NIH.Cg-Cdkn1atm1Led)
|
decreased lymphoma incidence
|
J:87536
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
decreased incidence of tumors by ionizing radiation induction
|
J:70894
|
Cdkn1btm2Jro/Cdkn1btm2Jro
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:103819
|
Cdkn1btm3Mlf/Cdkn1btm3Mlf Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor)
|
decreased tumor incidence
|
J:107588
|
Cdkn2aPctr1-DBA/2N/?
(involves: BALB/cAnPt * DBA/2N)
|
decreased tumor incidence
|
J:16958
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
(involves: 129P2/OlaHsd * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:125189
|
Cdkn2atm1Cjs/Cdkn2a+ Ppm1dtm1Lad/Ppm1dtm1Lad Tg(IghMyc)22Bri/0
(involves: 129 * C57BL * FVB/N * SJL)
|
decreased tumor incidence
|
J:120284
|
Cebpbtm1Es/Cebpbtm1Es Tg(KRT5-cre)5132Jlj/?
(involves: 129S1/Sv * C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:107334
|
Cebpbtm1Pfj/Cebpb+
(B6.Cg-Cebpbtm1Pfj)
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Cebpbtm1Pfj/Cebpbtm1Pfj
(B6.Cg-Cebpbtm1Pfj)
|
decreased incidence of induced tumors
|
J:73558
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Cebpbtm1Pfj/Cebpbtm1Pfj Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Chd1lGt(E305F08)Wrst/Chd1lGt(E305F08)Wrst
(involves: 129 * 129P2/OlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:302849
|
decreased tumor incidence
|
J:302849
|
Chek1tm2.1Sje/Chek1+ Trp53tm1Brn/Trp53tm1Brn Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB)
|
decreased tumor incidence
|
J:162126
|
Chek1tm2.1Sje/Chek1tm2.1Sje Trp53tm1Brn/Trp53tm1Brn Tg(MMTV-cre)#Mam/0
(involves: 129P2/OlaHsd * FVB)
|
decreased tumor incidence
|
J:162126
|
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J)
|
decreased lung tumor incidence
|
J:223336
|
Cops6Gt(RRI087)Byg/Cops6+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by ionizing radiation induction
|
J:172038
|
Cpt1cGt(XL823)Byg/Cpt1c+ Nf1tm1Tyj/Nf1+ Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased sarcoma incidence
|
J:228258
|
Ct55em1Xdzg/Ct55em1Xdzg
(involves: C57BL/6)
|
decreased incidence of induced tumors
|
J:280149
|
Ctnnb1tm1Mmt/Ctnnb1+ Cxcr4tm2Yzo/Cxcr4tm2Yzo Tg(Wap-cre)11738Mam/0 Tg(Wap-Hgf)402Mig/0
(FVB.Cg-Cxcr4tm2Yzo Ctnnb1tm1Mmt Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig)
|
decreased mammary gland tumor incidence in breeding females
|
J:206839
|
Cul4atm1.1Pz/Cul4atm1.1Pz Tg(KRT14-cre/ERT)20Efu/?
(involves: C57BL/6 * CD-1)
|
decreased incidence of tumors by UV induction
|
J:150427
|
Cyp1a2tm1Dwn/Cyp1a2tm1Dwn
(B6.129P2-Cyp1a2tm1Dwn)
|
decreased incidence of tumors by chemical induction
|
J:97596
|
Cyp1b1tm1Gonz/Cyp1b1tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:53827
|
Cyp2c23Gt(OST85045)Lex/Cyp2c23Gt(OST85045)Lex
(129-Cyp2c23Gt(OST85045)Lex)
|
decreased incidence of induced tumors
|
J:207597
|
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
|
decreased incidence of tumors by chemical induction
|
J:118150
|
Dancrem1.1Bcgen/Dancrem1.1Bcgen
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:329926
|
Dektm1Siwe/Dektm1Siwe
(involves: 129P2/OlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:146608
|
Del(11Stat5a-Stat5b)1Mam/+
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
decreased tumor incidence
|
J:122463
|
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
decreased tumor incidence
|
J:122463
|
Del(15Rr357-Rr303293)2Jta/Del(15Rr357-Rr303293)2Jta
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:257088
|
Dgkitm1Mtop/Dgkitm1Mtop Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NTac)
|
decreased incidence of induced tumors
|
J:99817
|
Dh/Dh+ H2d/H2d
(NZB.Cg-Dh)
|
decreased lymphoma incidence
|
J:12036
|
Dhx33em1Yazh/Dhx33+ Krastm4Tyj/Kras+
(involves: 129S4/SvJae)
|
decreased lung tumor incidence
|
J:299900
|
Dhx33em1Yazh/Dhx33em1Yazh Krastm4Tyj/Kras+
(involves: 129S4/SvJae)
|
decreased lung tumor incidence
|
J:299900
|
Dnajc27Gt(OST374030)Lex/Dnajc27Gt(OST374030)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:210622
|
Dnd1Ter/Dnd1Ter Sf1Gt(XD130)Byg/Sf1+
(involves: 129P2/OlaHsd * 129S1/SvImJ * 129T1/Sv)
|
decreased tumor incidence
|
J:164224
|
E2f4tm1Lees/E2f4tm1Lees Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
decreased tumor incidence
|
J:81082
|
Egfrwa2/Egfr+ Nf1tm1Fcr/Nf1+ Trp53tm1Brd/Trp53+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * C57BL/6JEi * C3H/HeSnJ)
|
decreased tumor incidence
|
J:95933
|
Egr1tm1Jmi/Egr1tm1Jmi Tg(Defcr2-TAg)#Jig/?
(involves: 129 * C57BL/6 * FVB/N)
|
decreased prostate gland tumor incidence
|
J:67125
|
decreased tumor incidence
|
J:67125
|
Eif2ak3tm1.2Drc/Eif2ak3tm1.2Drc Ptentm1Hwu/Ptentm1Hwu Tg(CAG-MYC,-GFP*)#Rugg/0 Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
decreased prostate gland tumor incidence
|
J:261540
|
Eif2s2Gt(XH413)Byg/Eif2s2+
(129-Eif2s2Gt(XH413)Byg Chr 19MOLF/Ei)
|
decreased incidence of induced tumors
|
J:146879
|
Eif4eGt(RRO036)Byg/Eif4e+ Krastm3Tyj/Kras+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased lung tumor incidence
|
J:224214
|
Eif4etm1.1Lfur/Eif4etm1.1Lfur Ptentm2.1Ppp/Ptentm2.1Ppp Tg(Pbsn-cre)4Prb/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased tumor incidence
|
J:163589
|
Endovtm1Ial/Endovtm1Ial
(involves: C57BL/6J * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:293118
|
Ephx1tm1Gonz/Ephx1tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56886
|
Epn1tm1.1Wami/Epn1tm1.1Wami Epn2tm1Ocr/Epn2tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:193966
|
Esamtm1Tq/Esamtm1Tq
(B6.129S6-Esamtm1Tq)
|
decreased tumor incidence
|
J:85314
|
Espl1Gt(XL058)Byg/Espl1+
(B6.129P2-Espl1Gt(XL058)Byg)
|
decreased tumor incidence
|
J:174926
|
Ets2tm1Rgo/Ets2tm5.1Rgo Ptentm1.1Mwst/Ptentm1.1Mwst Tg(S100a4-cre)1Gle/0
(involves: 129S2/SvPas * FVB/N)
|
decreased mammary gland tumor incidence
|
J:153747
|
Ets2tm1Rgo/Ets2tm5.1Rgo Tg(MMTV-PyVT)634Mul/0 Tg(S100a4-cre)1Gle/0
(involves: 129S2/SvPas * FVB/N)
|
decreased mammary gland tumor incidence
|
J:153747
|
F2rl1tm1Bpd/F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul/0
(B6.Cg-F2rl1tm1Bpd Tg(MMTV-PyVT)634Mul)
|
decreased mammary gland tumor incidence
|
J:138924
|
Fastm1Ach/Fastm1Ach Krastm4Tyj/Kras+ Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae)
|
decreased ovarian tumor incidence
|
J:161953
|
Fgf22tm1Rpgr/Fgf22tm1Rpgr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:187809
|
Fgfr3tm1Dor/Fgfr3tm1Dor Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-Fgf9,-EGFP)#Dor/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB)
|
decreased organ/body region tumor incidence
|
J:204282
|
Fgfr4tm1Cxd/Fgfr4tm1Cxd Tg(Myl2-FGF19)1Dfre/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:187236
|
decreased liver tumor incidence
|
J:187236
|
Fntbtm1Bbd/Fntbtm1.1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:98944
|
Fntbtm1Bbd/Fntbtm1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:98944
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:181296
|
Foxm1tm1Rhc/Foxm1tm1Rhc Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:89472
|
decreased liver tumor incidence
|
J:89472
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
decreased incidence of tumors by chemical induction
|
J:43880
|
decreased lymphoma incidence
|
J:30715
|
Foxn1nu/Foxn1nu Srcr/Srcr+
(involves: BALB/c * C57BL/6)
|
decreased tumor incidence
|
J:83618
|
Fxyd5em1Namje/Fxyd5em1Namje
(C57BL/6J-Fxyd5em1Namje)
|
decreased incidence of tumors by chemical induction
|
J:325989
|
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:137456
|
Gata6osem1Zfa/Gata6osem1Zfa
(C57BL/6-1010001N08Rikem1Zfa)
|
decreased incidence of tumors by chemical induction
|
J:268724
|
Gata6osem1Zfa/Gata6osem1Zfa ApcMin/Apc+
(involves: C57BL/6J)
|
decreased intestinal adenoma incidence
|
J:268724
|
Gct4CAST/Ei/Gct4CAST/Ei
(involves: CAST/Ei * SJL * SWR)
|
decreased tumor incidence
|
J:87114
|
Ggctem1.2Smoc/Ggctem1.2Smoc Krastm4Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased tumor incidence
|
J:317466
|
Ggta1tm1Jbl/Ggta1tm1Jbl
(involves: 129S2/SvPas)
|
decreased lung tumor incidence
|
J:90851
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Tacc3tm1.1Tno/Tacc3tm1.2Tno Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased lymphoma incidence
|
J:179414
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Krastm4Tyj/Kras+ Tg(Pdx1-cre)89.1Dam/0 Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi
(involves: 129 * C57BL/6 * CBA)
|
decreased gland tumor incidence
|
J:289183
|
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+ Hes1tm1.1Frad/Hes1tm1.1Frad Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased lymphoma incidence
|
J:167000
|
H2-Obvic1/H2-Obvic1
(I/LnJ)
|
decreased incidence of induced tumors
|
J:81554,
J:60602
|
H19tm1Tilg/H19+ Tg(CRP-TAg)60-3Urt/0
(involves: 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
decreased tumor incidence
|
J:90036
|
Hcs7C57BL/6J/?
(involves: C3H/HeJ * C57BL/6J)
|
decreased liver tumor incidence
|
J:31507
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:148086
|
Hipk1tm1Mak/Hipk1tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:99823
|
Hpcr1C57BL/6J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased hepatoma incidence
|
J:22501
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr1C57BL/6J/Hpcr1DBA/2J Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased hepatoma incidence
|
J:22501
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr1DBA/2J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased hepatoma incidence
|
J:22501
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased hepatoma incidence
|
J:22501
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr2DBA/2J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased hepatoma incidence
|
J:22501
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hrhr/Hrhr Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6 * SKH1)
|
decreased incidence of tumors by UV induction
|
J:117581
|
Hrhr/Hrhr Ptgs2tm1Unc/Ptgs2+
(involves: 129P2/OlaHsd * C57BL/6 * SKH1)
|
decreased incidence of tumors by UV induction
|
J:121635
|
Hrhr/Hrhr Tg(KRT14-Birc5)19Gros/0
(involves: C3H * C57BL/6 * SKH1)
|
decreased incidence of tumors by UV induction
|
J:95011
|
Hrastm1Mok/Hrastm1Mok
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased incidence of tumors by chemical induction
|
J:62962
|
Icostm1Flv/Icostm1Flv Rc3h1san/Rc3h1+
(involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu)
|
decreased lymphoma incidence
|
J:189087
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:194587
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased tumor incidence
|
J:138466
|
Igf2bp2tm1Mini/Igf2bp2tm1Mini
(B6.129P2-Igf2bp2tm1Mini)
|
decreased tumor incidence
|
J:271356
|
Ighg2cem1Wliu/Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu)
|
decreased incidence of induced tumors
|
J:322180
|
decreased incidence of tumors by chemical induction
|
J:322180
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * BALB/c)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Il2rgtm1Wjl/Il2rgtm1Wjl Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased incidence of tumors by ionizing radiation induction
|
J:109833
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:122816
|
Il6tm1Poli/Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli)
|
decreased incidence of induced tumors
|
J:42869
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:202764
|
Il6sttm1Ern/Il6sttm1Ern Tg(RP11-H2112)5Trme/0
(involves: 129S1/Sv * C57BL/6J * DBA/2J)
|
decreased stomach tumor incidence
|
J:234656
|
Il6sttm1Ern/Il6sttm1Ern Tg(RP11-H2112)9Trme/0
(involves: 129S1/Sv * C57BL/6J * DBA/2J)
|
decreased stomach tumor incidence
|
J:234656
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by UV induction
|
J:125760
|
decreased tumor incidence
|
J:125760
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
decreased incidence of tumors by chemical induction
|
J:111568
|
Il23atm1Dnax/Il23atm1Dnax
(B6.Cg-Il23atm1Dnax)
|
decreased incidence of tumors by chemical induction
|
J:111568
|
Ino80tm1.1Schg/Ino80+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J)
|
decreased lymphoma incidence
|
J:221224
|
Itgb1tm1Mll/Itgb1tm1Mll Tg(MMTV-cre)7Mul/0 Tg(MMTV-PyVT)634Mul/0
(involves: 129X1/SvJ * FVB/N)
|
decreased mammary gland tumor incidence
|
J:92547
|
Itgb1tm11.1Ref/Itgb1tm11.1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased incidence of tumors by chemical induction
|
J:176453
|
Itih4tm1Mish/Itih4tm1Mish Sptbn1tm1Mish/Sptbn1+
(involves: 129S6/SvEvTac * C57BL/6 * NIH Black Swiss)
|
decreased liver tumor incidence
|
J:132133
|
Kcmf1Gt(XE080)Byg/Kcmf1Gt(XE080)Byg Tg(Mt1-Tgfa)149Bri/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
decreased tumor incidence
|
J:162125
|
Kdm4cGt(897)Tgen/Kdm4c+
(B6.Cg-Kdm4cGt(897)Tgen)
|
decreased incidence of tumors by chemical induction
|
J:227280
|
KitW-v/Kit+ Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6)
|
decreased tumor incidence
|
J:88074
|
KitW-v/KitW-v Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6)
|
decreased tumor incidence
|
J:88074
|
KitlSl-d/KitlSl-d Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6 * DBA/2)
|
decreased tumor incidence
|
J:88074
|
Klk6tm1Gsot/Klk6+
(involves: C57BL/6)
|
decreased incidence of induced tumors
|
J:270051
|
decreased incidence of tumors by chemical induction
|
J:270051
|
Klk6tm1Gsot/Klk6tm1Gsot
(involves: C57BL/6)
|
decreased incidence of induced tumors
|
J:270051
|
decreased incidence of tumors by chemical induction
|
J:270051
|
Krasb/Krasb
(multiple strains)
|
decreased lung tumor incidence
|
J:17778,
J:17850
|
Krastm1Bbd/Kras+ Map2k1tm1Chrn/Map2k1tm1Chrn Map2k2tm1Chrn/Map2k2tm1Chrn
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
decreased classified tumor incidence
|
J:172200
|
Krastm1Bbd/Kras+ Mapk1tm1.1Hed/Mapk1tm1.1Hed Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ)
|
decreased classified tumor incidence
|
J:172200
|
Krastm1Bbd/Kras+ Raf1tm2Bacc/Raf1tm2Bacc
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased classified tumor incidence
|
J:172200
|
Krastm3Tyj/Kras+ Mir21atm1.1Eno/Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
decreased lung tumor incidence
|
J:164198
|
decreased tumor incidence
|
J:164198
|
Krastm3Tyj/Kras+ Pik3catm1Jdo/Pik3catm1Jdo
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)
|
decreased incidence of induced tumors
|
J:122866
|
decreased lung tumor incidence
|
J:122866
|
Krastm3Tyj/Kras+ Tg(CAG-Mir21,-EGFP)#Eno/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
decreased tumor incidence
|
J:164198
|
Krastm3Tyj/Krastm3Tyj Mir301tm1Yoli/Mir301tm1Yoli
(involves: 129S4/SvJae * C57BL/6J)
|
decreased lung tumor incidence
|
J:237900
|
decreased lymphoma incidence
|
J:237900
|
decreased skin tumor incidence
|
J:237900
|
decreased tumor incidence
|
J:237900
|
Krastm4Tyj/Kras+ Pik3r1tm1Lca/Pik3r1tm1Lca Pik3r2tm1Lca/Pik3r2tm1Lca
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased lung tumor incidence
|
J:142254
|
Krastm4Tyj/Kras+ Ptf1atm1(cre)Hnak/Ptf1a+ Ube2ftm1c(EUCOMM)Hmgu/Ube2ftm1c(EUCOMM)Hmgu
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
decreased tumor incidence
|
J:348744
|
Krastm4Tyj/Kras+ Rnf7Gt(XE423)Byg/Rnf7tm1.1Ysun
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased lung tumor incidence
|
J:207982
|
Krastm4Tyj/Kras+ Siva1tm1.1Att/Siva1tm1.2Att
(involves: 129S4/SvJae * C57BL/6)
|
decreased lung tumor incidence
|
J:223572
|
Krastm4Tyj/Kras+ Siva1tm1.2Att/Siva1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased lung tumor incidence
|
J:223572
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased incidence of induced tumors
|
J:154041
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR)
|
decreased incidence of tumors by chemical induction
|
J:124222
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(Scgb1a1-rtTA)1Jaw/0
(involves: 129S4/SvJae)
|
decreased incidence of induced tumors
|
J:154041
|
Krastm4Tyj/Kras+ Ube2cem1Gpt/Ube2cem1Gpt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased lung tumor incidence
|
J:333347
|
Krt10tm2Tmm/Krt10tm2Tmm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased incidence of induced tumors
|
J:93045
|
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh
(either: FVB.129-Pard3tm1Shoh Krt14tm1(cre)Wbm or (involves: 129P2/OlaHsd * 129S4/SvJae))
|
decreased incidence of tumors by chemical induction
|
J:192905
|
Ksr1tm1Kole/Ksr1tm1Kole Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:84644
|
Lig4tm1Icrf/Lig4tm1Icrf Trp53tm1Tyj/Trp53+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ))
|
decreased tumor incidence
|
J:111068
|
Lonp1tm1Otin/Lonp1+
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:221992
|
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:220689
|
Lrig2tm1.1Hhed/Lrig2tm1.1Hhed
(involves: 129 * C57BL/6 * FVB/N)
|
decreased incidence of induced tumors
|
J:205929
|
Lypd3tm1(KOMP)Vlcg/Lypd3tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased incidence of tumors by chemical induction
|
J:235771
|
Lyr2SL/Ni/Lyr2SL/Ni
(involves: SL/Kh * SL/Ni)
|
decreased lymphoma incidence
|
J:32436
|
LyrSTS/A/LyrSTS/A
(involves: BALB/cHeA * STS/A)
|
decreased lymphoma incidence
|
J:10558
|
Mapk14tm1.1Dvb/Mapk14+ Ppm1dtm1Lad/Ppm1dtm1Lad Tg(IghMyc)22Bri/0
(involves: 129S7/SvEvBrd * C57BL * FVB/N * SJL)
|
decreased tumor incidence
|
J:120284
|
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
Mapkapk2tm1.2Gkl/Mapkapk2tm1.2Gkl
(involves: BALB/cJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
MetPar4/Met+
(involves: BALB/cJ * SWR/J)
|
decreased lung tumor incidence
|
J:43176
|
Mgat3tm1Pst/Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:48441,
J:86643
|
Miftm1Dvd/Miftm1Dvd
(B6.129S4-Miftm1Dvd)
|
decreased incidence of tumors by chemical induction
|
J:126543
|
Mir21atm1Yoli/Mir21atm1Yoli
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:173464
|
Mir31em1Nju/Mir31em1Nju Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6J * FVB/N)
|
decreased mammary gland tumor incidence
|
J:271420
|
Mir301tm1Yoli/Mir301tm1Yoli
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:237900
|
decreased tumor incidence
|
J:237900
|
Mirc1tm2.1Aven/Mirc1tm2.1Aven Tg(ARR2/Pbsn-MYC)7Key/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J)
|
decreased prostate gland tumor incidence
|
J:223213
|
Mki67em1Dfis/Mki67em1Dfis
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:304800
|
Mmp1atm1Otin/Mmp1atm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:198586
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(B6.129S6-Mmp9tm1Tvu)
|
decreased tumor incidence
|
J:105098
|
Mmp9tm1Tvu/Mmp9tm1Tvu Rag2tm1Fwa/Rag2tm1Fwa
(B6.129S-Rag2tm1Fwa Mmp9tm1Tvu)
|
decreased tumor incidence
|
J:105098
|
Mmp9tm1Tvu/Mmp9tm1Tvu Tg(KRT14-HPV16)wt1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * FVB/N)
|
decreased tumor incidence
|
J:65699
|
Mmp11tm1Mrio/Mmp11tm1Mrio
(either: (involves: 129S2/SvPas * 129X1/SvJ) or (involves: 129S2/SvPas * 129X1/SvJ * BALB/c) or (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6J))
|
decreased incidence of tumors by chemical induction
|
J:79012
|
Mmp19tm1Amp/Mmp19tm1Amp
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:90802
|
Modc1C3H/HeJ/Modc1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
decreased tumor incidence
|
J:75743
|
Modc1C3H/HeJ/Modc1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased tumor incidence
|
J:75743
|
Modc2BALB/cJ/Modc2BALB/cJ
(involves: BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:101472
|
Modc2BALB/cJ/Modc2C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:101472
|
Mp53d1BALB/c/Mp53d1MSM
(involves: BALB/c-Trp53tm1Brd * MSM)
|
decreased lymphoma incidence
|
J:81940
|
Mp53d2BALB/c/Mp53d2MSM
(involves: BALB/c-Trp53tm1Brd * MSM)
|
decreased lymphoma incidence
|
J:81940
|
Mp53d3BALB/c/Mp53d3MSM
(involves: BALB/c-Trp53tm1Brd * MSM)
|
decreased incidence of tumors by ionizing radiation induction
|
J:81940
|
Mpgtm1Rhe/Mpgtm1Rhe
(B6.129P2-Mpgtm1Rhe)
|
decreased incidence of tumors by chemical induction
|
J:86644
|
Msmr1MSM/Ms/Msmr1MSM/Ms
(involves: MSM/Ms * SL/Kh)
|
decreased lymphoma incidence
|
J:34941
|
Msmr1MSM/Ms/Msmr1SL/Kh
(involves: MSM/Ms * SL/Kh)
|
decreased lymphoma incidence
|
J:34941
|
Msmr2MSM/Ms/Msmr2MSM/Ms
(involves: MSM/Ms * SL/Kh)
|
decreased lymphoma incidence
|
J:34941
|
Msmr2MSM/Ms/Msmr2SL/Kh
(involves: MSM/Ms * SL/Kh)
|
decreased lymphoma incidence
|
J:34941
|
MtdhGt(XB780)Byg/Mtdh+ Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul)
|
decreased mammary gland tumor incidence
|
J:214244
|
MtdhGt(XB780)Byg/Mtdh+ Tg(Wnt1)1Hev/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(Wnt1)1Hev)
|
decreased mammary gland tumor incidence
|
J:214244
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
(FVB.129P2-MtdhGt(XB780)Byg)
|
decreased incidence of tumors by chemical induction
|
J:214244
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul)
|
decreased mammary gland tumor incidence
|
J:214244
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg Tg(MMTVneu)202Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTVneu)202Mul)
|
decreased mammary gland tumor incidence
|
J:214244
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg Tg(Wnt1)1Hev/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(Wnt1)1Hev)
|
decreased mammary gland tumor incidence
|
J:214244
|
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))
|
decreased cardiovascular system tumor incidence
|
J:216688
|
decreased incidence of tumors by chemical induction
|
J:216688
|
decreased liver tumor incidence
|
J:216688
|
decreased lung tumor incidence
|
J:216688
|
decreased organ/body region tumor incidence
|
J:216688
|
Muc4tm1Skb/Muc4tm1Skb
(involves: 129 * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:234205
|
Myctm1Jlc/Myctm1Jlc
(involves: 129S7/SvEvBrd)
|
decreased tumor incidence
|
J:79427
|
Myctm2Fwa/Myc+ Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:319454
|
Myct1em1Choi/Myct1em1Choi Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N)
|
decreased mammary gland tumor incidence
|
J:303692
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
decreased liver tumor incidence
|
J:103464
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:162097
|
Ncapd2em1Cya/Ncapd2+
(C57BL/6N-Ncapd2em1Cya)
|
decreased incidence of tumors by chemical induction
|
J:310248
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1)
|
decreased incidence of induced tumors
|
J:88789
|
decreased mammary gland tumor incidence
|
J:88789
|
Nell1tm1Kuv/Nell1tm1Kuv Rb1tm2Brn/Rb1tm2Brn Trp53tm1Brn/Trp53tm1Brn Tg(BGLAP-cre)1Clem/0
(involves: 129 * FVB/NJ)
|
decreased osteosarcoma incidence
|
J:326989
|
Neu3tm1Yamk/Neu3tm1Yamk
(B6.129-Neu3tm1Yamk)
|
decreased incidence of tumors by chemical induction
|
J:189604
|
Nf1tm1Fcr/Nf1+ Tg(Cnp-EGFR)10Nrat/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
decreased tumor incidence
|
J:95933
|
Nf1tm1Tyj/? Nstr1A/J/? Trp53tm1Tyj/?
(involves: 129S2/SvPas * A/J * C57BL/6J)
|
decreased tumor incidence
|
J:105038
|
Nf1tm1Tyj/? Nstr2A/J/? Trp53tm1Tyj/?
(involves: 129S2/SvPas * A/J * C57BL/6J)
|
decreased tumor incidence
|
J:105038
|
Nf1tm1Tyj/? Trp53tm1Tyj/? Mastr129S4/SvJae/?
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6J)
|
decreased tumor incidence
|
J:92444
|
Nmral1Gt(S8-10A1)Sor/Nmral1Gt(S8-10A1)Sor Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Nmral1Gt(S8-10A1)Sor Tg(MMTV-PyVT)634Mul)
|
decreased mammary gland tumor incidence
|
J:282813
|
Nop53tm1Asuz/Nop53+
(B6.129P2-Nop53tm1Asuz)
|
decreased papilloma incidence
|
J:241062
|
Nos2tm1Lau/Nos2tm1Lau Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Nos2tm1Lau Tg(MMTV-PyVT)634Mul)
|
decreased tumor incidence
|
J:121391
|
Pak1em1Yuwa/Pak1+
(FVB/N-Pak1em1Yuwa)
|
decreased papilloma incidence
|
J:323200
|
Pak1em1Yuwa/Pak1em1Yuwa
(FVB/N-Pak1em1Yuwa)
|
decreased papilloma incidence
|
J:323200
|
Par1M. spretus/Par1M. spretus
(involves: A/J * M. spretus)
|
decreased incidence of tumors by chemical induction
|
J:120319
|
Par2BALB/c/?
(involves: A/J * BALB/c)
|
decreased incidence of tumors by chemical induction
|
J:36219
|
Par3A/J/Par3SM/J
(involves: A/J * SM/J)
|
decreased incidence of tumors by chemical induction
|
J:67468
|
Par3SM/J/Par3SM/J
(involves: A/J * SM/J)
|
decreased incidence of tumors by chemical induction
|
J:67468
|
Par5BALB/cJ/?
(involves: BALB/cJ * SWR/J)
|
decreased lung tumor incidence
|
J:43176
|
Pas9A/JOlaHsd/Pas9A/JOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:50533
|
Pas14A/J/?
(involves: A/J * C57BL/6J * M. spretus)
|
decreased lung tumor incidence
|
J:29218
|
Pas14A/J/?
(involves: A/J * C57BL/6J)
|
decreased lung tumor incidence
|
J:86399
|
Pas17M. spretus/?
(involves: A/J * C57BL/6J * M. spretus)
|
decreased lung tumor incidence
|
J:29218
|
PctmBALB/cAnPt/PctmBALB/cAnPt
(involves: BALB/cAnPt * DBA/2N)
|
decreased incidence of tumors by chemical induction
|
J:15235
|
Pctr2DBA/2N/?
(involves: BALB/cAnPt * DBA/2N)
|
decreased tumor incidence
|
J:16958
|
Pgbd5tm1.2Aken/Pgbd5tm1.2Aken Ptch1tm1Bjw/Ptch1tm1Bjw Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129 * C57BL/6J * C57BL/6NTac * FVB/N * SW)
|
decreased classified tumor incidence
|
J:346387
|
Pgcem1Hcz/Pgcem1Hcz
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:338079
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd)
|
decreased incidence of induced tumors
|
J:87522
|
Pik3catm1Jdo/Pik3catm1Jdo
(B6.129S7(Cg)-Pik3catm1Jdo)
|
decreased incidence of tumors by chemical induction
|
J:122866
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi Tg(MMTVneu)202Mul/0
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6J * FVB/N)
|
decreased mammary gland tumor incidence
|
J:152332
|
Pip4k2atm1.2Lca/Pip4k2atm1.2Lca Pip4k2bGt(Betageo)1Lca/Pip4k2b+ Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * 129S5/SvEvBrd)
|
decreased tumor incidence
|
J:205288
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:91526
|
Plbcq6FVB/NJ/?
(involves: FVB/NJ * M16i)
|
decreased mammary gland tumor incidence
|
J:136011
|
Plce1tm1Tkat/Plce1+
(involves: 129/Sv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:94952
|
Plce1tm1Tkat/Plce1tm1Tkat
(involves: 129/Sv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:94952
|
Pldmq1FVB/NJ/?
(involves: FVB/NJ * M16i)
|
decreased mammary gland tumor incidence
|
J:136011
|
Pold4em1Zzho/Pold4em1Zzho
(C57BL/6-Pold4em1Zzho)
|
decreased liver tumor incidence
|
J:331883
|
Ppm1dtm1Lad/Ppm1d+ Tg(IghMyc)22Bri/0
(involves: 129S7/SvEvBrd * C57BL * FVB/N * SJL)
|
decreased tumor incidence
|
J:120284
|
Ppm1dtm1Lad/Ppm1dtm1Lad Tg(IghMyc)22Bri/0
(involves: 129S7/SvEvBrd * C57BL * FVB/N * SJL)
|
decreased tumor incidence
|
J:120284
|
Prdx1tm1Yu/Prdx1tm1Yu
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:306075
|
Prkcqtm1Litt/Prkcqtm1Litt Tg(Lck-Notch3)#Issc/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased lymphoma incidence
|
J:96010
|
Prkdcscid/Prkdcscid Gnrh1hpg/Gnrh1hpg
(STOCK Prkdcscid Gnrh1hpg/Bm)
|
decreased tumor incidence
|
J:14443,
J:138840
|
Prkdcscid/Prkdcscid Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J)
|
decreased tumor incidence
|
J:47667
|
Prmt1tm1a(EUCOMM)Wtsi/Prmt1tm1a(EUCOMM)Wtsi Rb1tm3Tyj/Rb1tm3Tyj Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:245660
|
Ptentm1Hwu/Ptentm1Hwu Rictortm1.1Mgn/Rictortm1.1Mgn
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased tumor incidence
|
J:144810
|
Ptentm1Hwu/Ptentm1Hwu Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)
|
decreased tumor incidence
|
J:124208
|
Ptentm1Rps/Pten+ RictorGt(RRR347)Byg/Rictor+
(involves: 129P2/OlaHsd * 129S1/Sv * BALB/c * C57BL/6)
|
decreased tumor incidence
|
J:144810
|
Ptger1tm1Sna/Ptger1tm1Sna
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
decreased incidence of tumors by chemical induction
|
J:95533
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
decreased incidence of tumors by chemical induction
|
J:116015
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
decreased incidence of tumors by chemical induction
|
J:73944
|
Ptgs2tm1Jed/Ptgs2tm1Jed Stk11tm1Tpm/Stk11+
(involves: 129S7/SvEvBrd * C57BL/6 * CD-1)
|
decreased tumor incidence
|
J:93361
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:158426
|
Ptk2tm1Gwm/Ptk2tm1Gwm Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:94680
|
Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:194458
|
PtprjScc1-r/PtprjScc1-r
(involves: BALB/cHeA * STS/A)
|
decreased incidence of tumors by chemical induction
|
J:31355
|
Pvrtm1Hfuk/Pvr+
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:143250
|
Pvrtm1Hfuk/Pvrtm1Hfuk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:143250
|
Pycardtm1Ayaz/Pycardtm1Ayaz Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Ralgdstm1Cjm/Ralgdstm1Cjm
(involves: 129X1/SvJ * MF1)
|
decreased incidence of tumors by chemical induction
|
J:96936
|
Rb1tm3Tyj/Rb1+ Sox2tm4.1Skn/Sox2+ Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:318885
|
Rb1tm3Tyj/Rb1+ Sox2tm4.1Skn/Sox2tm4.1Skn Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:318885
|
Rbm38tm1.1Xch/Rbm38tm1.1Xch Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased tumor incidence
|
J:216929
|
Rbm38tm1.1Xch/Rbm38tm1.1Xch Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased sarcoma incidence
|
J:216929
|
decreased tumor incidence
|
J:216929
|
Retnlbtm1Lex/Retnlbtm1Lex
(B6.129S5-Retnlbtm1Lex)
|
decreased incidence of tumors by chemical induction
|
J:235058
|
Rgv1C57BL/6/Rgv1C57BL/6
(involves: C3Hf/Bi * C57BL/6)
|
decreased incidence of induced tumors
|
J:5011
|
Rhojtm1.2Auem/Rhojtm1.2Auem Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * CBA/JNCrlj * FVB/N)
|
decreased mammary gland tumor incidence
|
J:208154
|
Ril1A/J/Ril1A/J
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of tumors by ionizing radiation induction
|
J:6610
|
Ril1A/J/Ril1C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of tumors by ionizing radiation induction
|
J:6610
|
Ril2A/J/Ril2C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of induced tumors
|
J:6610
|
Ril2C57BL/10ScSn/Ril2C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of tumors by ionizing radiation induction
|
J:6610
|
Ril3A/J/Ril3C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of tumors by ionizing radiation induction
|
J:6610
|
Ril3C57BL/10ScSn/Ril3C57BL/10ScSn
(involves: A/J * C57BL/10ScSn)
|
decreased incidence of tumors by ionizing radiation induction
|
J:6610
|
Ripk2tm1Flv/Ripk2tm1Flv
(C.129S1(B6)-Ripk2tm1Flv/Tvg)
|
decreased tumor incidence following infection
|
J:329456
|
Rnf128em1Tvg/Rnf128em1Tvg
(BALB/cJ-Rnf128em1Tvg)
|
decreased tumor incidence following infection
|
J:329456
|
Rpl27aSfa/Rpl27a+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J)
|
decreased lymphoma incidence
|
J:174216
|
Rr420em1Itok/Rr420em1Itok Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:319454
|
Rr420tm1.1Itok/Rr420tm1.1Itok Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:319454
|
RrsvSW/RrsvSW
(involves: A/WySnJ * SW)
|
decreased incidence of induced tumors
|
J:6009
|
RrsvSW/RrsvSW
(involves: CBA/J * SW)
|
decreased incidence of induced tumors
|
J:6009
|
Runx3tm1.1Itok/Runx3tm1.1Itok Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:319454
|
Runx3tm1Itan/Runx3+ Trp53tm1Brn/Trp53tm1Brn Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
decreased osteosarcoma incidence
|
J:319454
|
Sdc1tm1Cma/Sdc1+ Tg(Wnt1)1Hev/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased tumor incidence
|
J:63122
|
Sdc1tm1Cma/Sdc1tm1Cma Tg(Wnt1)1Hev/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased tumor incidence
|
J:63122
|
seb/seb
(Him:OF1)
|
decreased tumor incidence
|
J:20987
|
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased tumor incidence
|
J:106671
|
Serpinb9bem#Tvg/Serpinb9bem#Tvg
(BALB/cJ-Serpinb9bem#Tvg)
|
decreased tumor incidence following infection
|
J:329456
|
Skiltm1.1Kluo/Skiltm1.1Kluo
(B6.129P2-Skiltm1.1Kluo)
|
decreased incidence of tumors by chemical induction
|
J:154718
|
Skts1M. spretus/?
(involves: M. spretus * NIH)
|
decreased tumor incidence
|
J:27733
|
Skts16Car-R/Skts16Car-R
(involves: Car-R * Car-S)
|
decreased tumor incidence
|
J:68404
|
Skts16Car-R/Skts16Car-S
(involves: Car-R * Car-S)
|
decreased tumor incidence
|
J:68404
|
Slc3a2tm1.1Merl/Slc3a2+ Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum)
|
decreased incidence of tumors by chemical induction
|
J:173946
|
Slc6a14tm1Gana/Slc6a14tm1Gana Tg(MMTVneu)202Mul/0
(involves: FVB/N)
|
decreased mammary gland tumor incidence
|
J:226105
|
Slc25a11em1Syki/Slc25a11+ Krastm3Tyj/Kras+
(involves: 129S * C57BL/6)
|
decreased lung tumor incidence
|
J:294965
|
Sox9em1(cre/ERT2)Tchn/Sox9+ Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:322311
|
Spntm1Bam/Spntm1Bam
(B6;129S4-Spntm1Bam/J)
|
decreased tumor incidence
|
J:88253
|
Spp1tm1Blh/Spp1tm1Blh
(129S6/SvEvTac-Spp1tm1Blh)
|
decreased incidence of tumors by chemical induction
|
J:112122
|
Srcr/Srcr+
(BALB/c-Srcr/Cui)
|
decreased tumor incidence
|
J:83618
|
Srcr/Srcr+
(B6.C-Srcr/Cui)
|
decreased tumor incidence
|
J:83618
|
Srcr/Srcr+
(CAST.C-Srcr/Cui)
|
decreased tumor incidence
|
J:83618
|
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas)
|
decreased incidence of tumors by chemical induction
|
J:184720
|
Stat3tm2Aki/Stat3tm2Aki Tg(KRT5-cre/ERT2)AJdg/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:138529
|
Stk11tm1Tpm/Stk11+
(involves: 129S7/SvEvBrd * C57BL/6 * CD-1)
|
decreased tumor incidence
|
J:93361
|
Strapem1Pkda/Strap+
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:245661
|
Suds3tm1.1Rdp/Suds3+ Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * FVB)
|
decreased tumor incidence
|
J:117829
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased incidence of induced tumors
|
J:74001
|
decreased incidence of tumors by chemical induction
|
J:96945
|
Terctm1Rdp/Terctm1Rdp Tg(KRT5-Tert)8043Blas/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * DBA/2 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:96945
|
Terttm1Rdp/Terttm1Rdp
(B6.Cg-Terttm1Rdp)
|
decreased incidence of tumors by chemical induction
|
J:108914
|
decreased liver tumor incidence
|
J:108914
|
Tg(Bglap2-TAg)1Rkho/0 Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * FVB/N)
|
decreased osteosarcoma incidence
|
J:234128
|
Tg(CAG-Aes,-ALPP)1Lbe/0 Tg(CAG-Tle1,-ALPP)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased lung tumor incidence
|
J:106684
|
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
decreased tumor incidence
|
J:158388
|
Tg(CAG-SAC/EGFP)35Rang/0
(involves: C3H * C57BL/6)
|
decreased liver tumor incidence
|
J:125633
|
decreased lymphoma incidence
|
J:125633
|
decreased tumor incidence
|
J:125633
|
Tg(CAG-SAC/EGFP)35Rang/0 Tg(TRAMP)8247Ng/0
(involves: C3H * C57BL/6)
|
decreased tumor incidence
|
J:125633
|
Tg(Ela-KRAS*G12D)9Eps/0 Tgfbr1tm1Bopa/Tgfbr1+ Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: 129S1/SvImJ * C57BL/6 * FVB)
|
decreased gland tumor incidence
|
J:231759
|
Tg(KRT14-Birc5)19Gros/0
(involves: C3H * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:81530
|
Tg(KRT14-Birc5)19Gros/0 Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C3H * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:81530
|
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon/0
(B6.Cg-Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon)
|
decreased incidence of tumors by chemical induction
|
J:184388
|
Tg(MGMT)3Bec/Tg(MGMT)3Bec
(involves: NMRI)
|
decreased incidence of tumors by chemical induction
|
J:92925
|
Tg(MMTV-PyVT)634Mul/0
(multiple strains)
|
decreased mammary gland tumor incidence
|
J:48854
|
Tg(MMTVTGFB1)46Hlm/0
(involves: C57BL/6 * DBA/2)
|
decreased incidence of tumors by chemical induction
|
J:71696
|
Tg(Mx1-cre)1Cgn/0 Zmiz1tm1c(EUCOMM)Hmgu/Zmiz1tm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)
|
decreased incidence of induced tumors
|
J:234445
|
Tg(Pbsn-IGF1*)5305Ng/0 Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * FVB/N)
|
decreased tumor incidence
|
J:144539
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased incidence of tumors by chemical induction
|
J:182671
|
Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-MYC)36Bop/0
(Not Specified)
|
decreased tumor incidence
|
J:169920
|
Tg(Trp53)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased incidence of tumors by chemical induction
|
J:80311
|
decreased tumor incidence
|
J:80311
|
Tg(TRP53)4Dgj/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * FVB)
|
decreased lymphoma incidence
|
J:162466
|
Tg(TRP53*R72P)7Dgj/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * FVB)
|
decreased lymphoma incidence
|
J:162466
|
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1)
|
decreased tumor incidence
|
J:73757
|
Tg(Trp53R172L)4491Jmr/0
(involves: FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:101547
|
Tg(Vil1-PPARGC1A)#Amos/0
(involves: FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:171361
|
Tgfb1i1tm1.2Cet/Tgfb1i1tm1.2Cet Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased mammary gland tumor incidence
|
J:241234
|
Thyls2BALB/c/?
(involves: BALB/c * MSM)
|
decreased incidence of tumors by ionizing radiation induction
|
J:87704
|
Tiam1tm1Jgc/Tiam1+
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:77148
|
Tiam1tm1Jgc/Tiam1tm1Jgc
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:77148
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
decreased liver tumor incidence
|
J:143870
|
decreased lung tumor incidence
|
J:143870
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:162097
|
Tlr4tm1Aki/Tlr4tm1Aki
(B6.129P2-Tlr4tm1Aki)
|
decreased incidence of tumors by chemical induction
|
J:135620
|
Tlyr1C57BL/6J/Tlyr1C57BL/6J
(involves: C57BL/6J * M. spretus)
|
decreased tumor incidence
|
J:79055
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
Tnftm1Gkl/Tnftm1Gkl
(C.129S-Tnftm1Gkl)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
Tnfaip8l3tm1a(KOMP)Mbp/Tnfaip8l3tm1a(KOMP)Mbp
(C57BL/6N-Atm1Brd Tnfaip8l3tm1a(KOMP)Mbp/MbpMmucd)
|
decreased incidence of tumors by chemical induction
|
J:217197
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
decreased tumor incidence
|
J:66448
|
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:241611
|
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased tumor incidence
|
J:226880
|
Trem1tm1.1Ahoru/Trem1tm1.1Ahoru
(C57BL/6-Trem1tm1.1Ahoru)
|
decreased incidence of tumors by chemical induction
|
J:191035
|
Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(B6.129P2-Trim27Gt(XP0484)Wtsi)
|
decreased incidence of tumors by chemical induction
|
J:189317
|
Trp53tm1Brd/Trp53tm1Brd
(NIHOla.129S7-Trp53tm1Brd)
|
decreased incidence of tumors by chemical induction
|
J:93298
|
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased tumor incidence
|
J:73757
|
Trp53tm1Snj/Trp53tm1Snj
(involves: C57BL/6)
|
decreased tumor incidence
|
J:87687
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J)
|
decreased tumor incidence
|
J:104347
|
Tspan3Gt(NPX312)Byg/Tspan3Gt(NPX312)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased leukemia incidence
|
J:231800
|
Uqcc3em1Hya/Uqcc3em1Hya Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2)
|
decreased incidence of induced tumors
|
J:306534
|
Uri1tm1.1Ndj/Uri1+ Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj)
|
decreased incidence of tumors by chemical induction
|
J:217463
|
Usp4em1Pwa/Usp4em1Pwa
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:298778
|
Zdhhc9tm1Lex/Y Nrastm1Tyj/Nrastm1Tyj Tg(Mx1-cre)1Cgn/0
(involves: 129S5/SvEvBrd * C57BL/6 * CBA)
|
decreased leukemia incidence
|
J:231488
|
Zfp280cem1Xss/Zfp280cem1Xss
(C57BL/6J-Zfp280cem1Xss)
|
decreased incidence of tumors by chemical induction
|
J:331404
|
Zfp746em1Jhsn/Zfp746em1Jhsn
(C57BL/6-Zfp746em1Jhsn)
|
decreased incidence of tumors by chemical induction
|
J:344819
|
Zfp871tm1a(EUCOMM)Wtsi/Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd)
|
decreased lymphoma incidence
|
J:317166
|
Zmynd8em1Lwb/Zmynd8em1Lwb Tg(MMTV-cre)4Mam/0 Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB)
|
decreased mammary gland tumor incidence
|
J:326848
|
Zmynd8em1Lwb/Zmynd8em1Lwb Tg(MMTV-PyVT)634Mul/0 Tg(KRT14-cre)1Amc/0
(involves: C57BL/6N * CBA * FVB)
|
decreased mammary gland tumor incidence
|
J:326848
|